JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.17% |
| 2 | Financials | 10.12% |
| 3 | Consumer Discretionary | 9.84% |
| 4 | Healthcare | 7.97% |
| 5 | Communication Services | 6.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ECHO
5026
CALL
EchoStar
ECHO
$26.7B
| $344K | ﹤0.01% |
15,000
| – | – |
|
|
ECHO
5027
PUT
EchoStar
ECHO
$26.7B
| $344K | ﹤0.01% |
15,000
| – | – |
|
5028
Genie Energy
GNE
$383M
| $343K | ﹤0.01% |
21,993
+8,625
| +65% | +$135K |
|
5029
VanEck Preferred Securities ex Financials ETF
PFXF
$2.48B
| $342K | ﹤0.01% |
19,821
+19,744
| +25,642% | +$355K |
|
|
TEF
5030
DELISTED
Telefonica
TEF
| $342K | ﹤0.01% |
84,992
+49,580
| +140% | +$223K |
|
5031
Atossa Therapeutics
ATOS
$25.9M
| $341K | ﹤0.01% |
24,086
+14,110
| +141% | +$275K |
|
5032
EVI Industries
EVI
$211M
| $341K | ﹤0.01% |
20,829
+10,488
| +101% | +$200K |
|
5033
Superior Group of Companies
SGC
$208M
| $340K | ﹤0.01% |
20,593
-19,309
| -48% | -$310K |
|
|
RDNW
5034
RideNow Group
RDNW
$248M
| $340K | ﹤0.01% |
62,657
+38,778
| +162% | +$215K |
|
5035
NEOS S&P 500 High Income ETF
SPYI
$11.4B
| $340K | ﹤0.01% |
6,694
-132
| -2% | -$6.84K |
|
5036
W&T Offshore
WTI
$554M
| $339K | ﹤0.01% |
203,997
-2,303
| -1% | -$4.6K |
|
5037
PUT
TotalEnergies
TTE
$196B
| $338K | ﹤0.01% |
6,200
| – | – |
|
5038
X4 Pharmaceuticals
XFOR
$418M
| $337K | ﹤0.01% |
15,322
+12,773
| +501% | +$204K |
|
5039
Invesco S&P 500 Equal Weight Materials ETF
RSPM
$184M
| $336K | ﹤0.01% |
10,326
+3,730
| +57% | +$134K |
|
|
DFTX
5040
Definium Therapeutics
DFTX
$5.73B
| $335K | ﹤0.01% |
48,158
+11,163
| +30% | +$76.8K |
|
5041
First Trust Nasdaq Semiconductor ETF
FTXL
$1.38B
| $333K | ﹤0.01% |
3,817
+2,916
| +324% | +$264K |
|
5042
CNA Financial
CNA
$13.8B
| $332K | ﹤0.01% |
6,866
-21,202
| -76% | -$1.04M |
|
5043
Liquidia Corp
LQDA
$6.66B
| $332K | ﹤0.01% |
28,205
-207,188
| -88% | -$2.26M |
|
5044
iShares MSCI India Small-Cap ETF
SMIN
$771M
| $332K | ﹤0.01% |
4,338
-7,412
| -63% | -$607K |
|
|
USARW
5045
DELISTED
USA Rare Earth Inc Warrant
USARW
| – | – |
0
| – | – |
|
5046
McEwen Inc
MUX
$1.15B
| $330K | ﹤0.01% |
42,378
+42,363
| +282,420% | +$383K |
|
5047
Rentokil
RTO
$12B
| $329K | ﹤0.01% |
13,003
+6,200
| +91% | +$157K |
|
5048
ARS Pharmaceuticals
SPRY
$562M
| $328K | ﹤0.01% |
31,112
-1,710
| -5% | -$23.9K |
|
5049
Everspin Technologies
MRAM
$460M
| $328K | ﹤0.01% |
51,346
-7,322
| -12% | -$45.4K |
|
5050
Seaboard Corp
SEB
$4.18B
| $328K | ﹤0.01% |
135
-168
| -55% | -$462K |
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 510 new, 3,353 increased, 2,466 reduced and 523 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 510 new positions and closed 523 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.